产品编号 |
bs-41432P |
英文名称 |
Recombinant SARS-Cov-2 Papain-Like Protease, His
|
中文名称 |
重组SARS-CoV-2 (2019-nCoV) Papain-Like Protease |
别 名 |
Papain-like Protease; PLpro; PL-PRO; pp1a; Replicase polyprotein 1a; Recombinant SARS-Cov-2 Papain-Like Protease, His 新冠病毒PLpro; 新冠PLpro; SARS-CoV-2 PLpro; |
理论分子量 |
35.8 kDa |
检测分子量 |
26 |
性 状 |
Liquid |
浓 度 |
>0.5 mg/ml |
物 种 |
SARS-Cov-2 |
序 列 |
1564-1880/7096 |
纯 度 |
>90% as determined by SDS-PAGE |
纯化方法 |
AC |
内毒素 |
Not analyzed |
表达系统 |
E.coli |
活性 |
Not tested |
标签 |
His |
保存条件 |
Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事项 |
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
产品介绍 |
Replication of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) requires proteolytic processing of the replicase polyprotein by two viral cysteine proteases, a chymotrypsin-like protease (3CLpro) and a papain-like protease (PLpro). These proteases are important targets for development of antiviral drugs that would inhibit viral replication and reduce mortality associated with outbreaks of SARS-CoV. PLpro is a cysteine protease located within the non-structural protein 3 (NS3) section of the viral polypeptide. PLPro activity is required to process the viral polyprotein into functional, mature subunits; specifically, PLPro cleaves a site at the amino-terminus of the viral replicase region. In addition to its role in viral protein maturation, PLPro possesses a deubiquitinating and deISGylating activity. In vivo, this protease antagonizes innate immunity by inhibiting IRF3-induced production of type I interferons.
|
|
|